£5.5m funding award for Centre for Trials Research

The Centre for Trials Research has been given a £5.5m grant to further develop its ground-breaking cancer research, which is already making a difference to patients’ lives.

The five year funding – from Cancer Research UK – will allow doctors and scientists to continue researching better and kinder treatments for patients, including in areas of specialism such as acute myeloid leukaemia (AML).

The grant – which was awarded as part of a UK-wide competitive process – was based on the previous work that has been done through the Centre for Trials Research, as well as research proposals that can be delivered by the largest team of academic clinical trials staff in Wales.

“As a result of our research, we have seen a transformation in the way AML can be treated. We have pioneered designs that allow patients access to different treatments at different stages of their leukaemia journey.“

“We are now bringing the lessons learned forward into other cancer treatments to allow patients at all stages of their cancer journey access to novel therapies,” said Professor Robert Hills, AML Lead, Cardiff University (based in the Centre for Trials Research).

First published: @ResearchWales Issue 4, June 2018